• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由于Na1.4第一结构域的新型突变导致的钠通道性肌强直

Sodium Channel Myotonia Due to Novel Mutations in Domain I of Na1.4.

作者信息

Pagliarani Serena, Lucchiari Sabrina, Scarlato Marina, Redaelli Elisa, Modoni Anna, Magri Francesca, Fossati Barbara, Previtali Stefano C, Sansone Valeria A, Lecchi Marzia, Lo Monaco Mauro, Meola Giovanni, Comi Giacomo P

机构信息

Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Department of Neurology and INSPE, IRCCS Ospedale San Raffaele, Milan, Italy.

出版信息

Front Neurol. 2020 Apr 29;11:255. doi: 10.3389/fneur.2020.00255. eCollection 2020.

DOI:10.3389/fneur.2020.00255
PMID:32411069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7201054/
Abstract

Sodium channel myotonia is a form of muscle channelopathy due to mutations that affect the Na1.4 channel. We describe seven families with a series of symptoms ranging from asymptomatic to clearly myotonic signs that have in common two novel mutations, p.Ile215Thr and p.Gly241Val, in the first domain of the Na1.4 channel. The families described have been clinically and genetically evaluated. p.Ile215Thr and p.Gly241Val lie, respectively, on extracellular and intracellular loops of the first domain of the Na1.4 channel. We assessed that the p.Ile215Thr mutation can be related to a founder effect in people from Southern Italy. Electrophysiological evaluation of the channel function showed that the voltage dependence of the activation for both the mutant channels was significantly shifted toward hyperpolarized potentials (Ile215Thr: -28.6 ± 1.5 mV and Gly241Val: -30.2 ± 1.3 mV vs. WT: -18.5 ± 1.3 mV). The slow inactivation was also significantly affected, whereas fast inactivation showed a different behavior in the two mutants. We characterized two novel mutations of the gene expanding the knowledge about genetics of mild forms of myotonia, and we present, to our knowledge, the first homozygous patient with sodium channel myotonia.

摘要

钠通道性肌强直是一种由于影响Na1.4通道的突变而导致的肌肉通道病。我们描述了七个家族,这些家族具有一系列症状,从无症状到明显的肌强直体征,它们在Na1.4通道的第一个结构域中共有两个新的突变,即p.Ile215Thr和p.Gly241Val。所描述的家族已经进行了临床和基因评估。p.Ile215Thr和p.Gly241Val分别位于Na1.4通道第一个结构域的细胞外环和细胞内环上。我们评估p.Ile215Thr突变可能与意大利南部人群中的奠基者效应有关。对通道功能的电生理评估表明,两种突变通道激活的电压依赖性均显著向超极化电位偏移(Ile215Thr:-28.6±1.5 mV,Gly241Val:-30.2±1.3 mV,而野生型为-18.5±1.3 mV)。慢失活也受到显著影响,而快失活在两种突变体中表现出不同的行为。我们鉴定了该基因的两个新突变,扩展了对轻度肌强直遗传学的认识,并且据我们所知,我们展示了首例钠通道性肌强直的纯合子患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7290/7201054/f494f6903d15/fneur-11-00255-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7290/7201054/707adbcb19df/fneur-11-00255-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7290/7201054/dc77275c3b02/fneur-11-00255-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7290/7201054/5031eb7c4ab5/fneur-11-00255-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7290/7201054/f494f6903d15/fneur-11-00255-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7290/7201054/707adbcb19df/fneur-11-00255-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7290/7201054/dc77275c3b02/fneur-11-00255-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7290/7201054/5031eb7c4ab5/fneur-11-00255-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7290/7201054/f494f6903d15/fneur-11-00255-g0004.jpg

相似文献

1
Sodium Channel Myotonia Due to Novel Mutations in Domain I of Na1.4.由于Na1.4第一结构域的新型突变导致的钠通道性肌强直
Front Neurol. 2020 Apr 29;11:255. doi: 10.3389/fneur.2020.00255. eCollection 2020.
2
A C-terminal skeletal muscle sodium channel mutation associated with myotonia disrupts fast inactivation.一种与肌强直相关的C末端骨骼肌钠通道突变会破坏快速失活。
J Physiol. 2005 Jun 1;565(Pt 2):371-80. doi: 10.1113/jphysiol.2005.082909. Epub 2005 Mar 17.
3
N1366S mutation of human skeletal muscle sodium channel causes paramyotonia congenita.人类骨骼肌钠离子通道 N1366S 突变导致先天性副肌强直症。
J Physiol. 2017 Nov 15;595(22):6837-6850. doi: 10.1113/JP274877. Epub 2017 Oct 15.
4
Changes of Resurgent Na Currents in the Na1.4 Channel Resulting from an Mutation Contributing to Sodium Channel Myotonia.导致钠离子通道肌强直突变的钠通道 Na1.4 电流的再生变化。
Int J Mol Sci. 2020 Apr 8;21(7):2593. doi: 10.3390/ijms21072593.
5
Biophysical characterization of M1476I, a sodium channel founder mutation associated with cold-induced myotonia in French Canadians.M1476I 钠离子通道致病变异的生物物理特性研究,该突变与法裔加拿大人的低温诱发肌强直相关。
J Physiol. 2012 Jun 1;590(11):2629-44. doi: 10.1113/jphysiol.2011.223461. Epub 2012 Jan 16.
6
Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate.肌强直性营养不良 hNav1.4 钠通道变体的药物遗传学位于快速失活门附近。
Pharmacol Res. 2019 Mar;141:224-235. doi: 10.1016/j.phrs.2019.01.004. Epub 2019 Jan 3.
7
Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.非营养不良性肌强直:客观和患者报告结局的前瞻性研究。
Brain. 2013 Jul;136(Pt 7):2189-200. doi: 10.1093/brain/awt133. Epub 2013 Jun 13.
8
Idiopathic generalized epilepsy in a family with SCN4A-related myotonia.家族性 SCN4A 相关性肌强直的特发性全面性癫痫。
Epilepsia Open. 2024 Jun;9(3):951-959. doi: 10.1002/epi4.12920. Epub 2024 Mar 27.
9
Coexistence of SCN4A and CLCN1 mutations in a family with atypical myotonic features: A clinical and functional study.一个具有非典型肌强直特征的家族中SCN4A和CLCN1突变共存:一项临床和功能研究。
Exp Neurol. 2023 Apr;362:114342. doi: 10.1016/j.expneurol.2023.114342. Epub 2023 Jan 28.
10
Diverse biophysical mechanisms in voltage-gated sodium channel Na1.4 variants associated with myotonia.与肌强直相关的电压门控钠离子通道 Na1.4 变体的多种生物物理机制。
FASEB J. 2024 Aug 31;38(16):e23883. doi: 10.1096/fj.202400867R.

引用本文的文献

1
The Therapeutic Role of Perampanel in Treating Pediatric Patients With Dravet Syndrome: A Scoping Review.吡仑帕奈在治疗儿童Dravet综合征中的治疗作用:一项范围综述
Cureus. 2024 Jul 20;16(7):e65017. doi: 10.7759/cureus.65017. eCollection 2024 Jul.
2
Idiopathic generalized epilepsy in a family with SCN4A-related myotonia.家族性 SCN4A 相关性肌强直的特发性全面性癫痫。
Epilepsia Open. 2024 Jun;9(3):951-959. doi: 10.1002/epi4.12920. Epub 2024 Mar 27.
3
The Clinical, Myopathological, and Genetic Analysis of 20 Patients With Non-dystrophic Myotonia.

本文引用的文献

1
Myotonia in a patient with a mutation in an S4 arginine residue associated with hypokalaemic periodic paralysis and a concomitant synonymous CLCN1 mutation.一位 S4 精氨酸残基突变相关低钾周期性瘫痪和同时伴有同义 CLCN1 突变患者的肌强直。
Sci Rep. 2019 Nov 26;9(1):17560. doi: 10.1038/s41598-019-54041-0.
2
Dysfunction of NaV1.4, a skeletal muscle voltage-gated sodium channel, in sudden infant death syndrome: a case-control study.Nav1.4 功能障碍,一种骨骼肌电压门控钠离子通道,与婴儿猝死综合征有关:一项病例对照研究。
Lancet. 2018 Apr 14;391(10129):1483-1492. doi: 10.1016/S0140-6736(18)30021-7. Epub 2018 Apr 5.
3
Sodium Channelopathies of Skeletal Muscle.
20例非萎缩性肌强直患者的临床、肌病理及遗传学分析
Front Neurol. 2022 Mar 8;13:830707. doi: 10.3389/fneur.2022.830707. eCollection 2022.
4
Cannabidiol Selectively Binds to the Voltage-Gated Sodium Channel Na1.4 in Its Slow-Inactivated State and Inhibits Sodium Current.大麻二酚在其慢失活状态下选择性结合电压门控钠通道Na1.4并抑制钠电流。
Biomedicines. 2021 Sep 2;9(9):1141. doi: 10.3390/biomedicines9091141.
5
Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine.靶向治疗骨骼肌肉离子通道病:系统评价与精准医学的发展。
J Neuromuscul Dis. 2021;8(3):357-381. doi: 10.3233/JND-200582.
骨骼肌钠通道病
Handb Exp Pharmacol. 2018;246:309-330. doi: 10.1007/164_2017_52.
4
Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or 'classical' congenital myopathy.SCN4A基因的功能丧失突变会导致严重的胎儿运动减退或“经典”先天性肌病。
Brain. 2016 Mar;139(Pt 3):674-91. doi: 10.1093/brain/awv352. Epub 2015 Dec 22.
5
Muscle channelopathies: recent advances in genetics, pathophysiology and therapy.肌肉离子通道病:遗传学、病理生理学及治疗的最新进展
Curr Opin Neurol. 2014 Oct;27(5):583-90. doi: 10.1097/WCO.0000000000000127.
6
miRNA in the regulation of ion channel/transporter expression.miRNA 在调控离子通道/转运体表达中的作用。
Compr Physiol. 2013 Apr;3(2):599-653. doi: 10.1002/cphy.c110002.
7
Severe neonatal episodic laryngospasm due to de novo SCN4A mutations: a new treatable disorder.严重新生儿发作性喉痉挛与 SCN4A 基因突变有关:一种新的可治疗疾病。
Neurology. 2010 Aug 17;75(7):641-5. doi: 10.1212/WNL.0b013e3181ed9e96.
8
Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis.骨骼肌肉通道病:非营养不良性肌强直和周期性瘫痪。
Curr Opin Neurol. 2010 Oct;23(5):466-76. doi: 10.1097/WCO.0b013e32833cc97e.
9
The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.非营养不良性肌强直症:分子发病机制、诊断与治疗。
Brain. 2010 Jan;133(Pt 1):9-22. doi: 10.1093/brain/awp294. Epub 2009 Nov 16.
10
Homozygosity for dominant mutations increases severity of muscle channelopathies.纯合显性突变可增加肌通道病的严重程度。
Muscle Nerve. 2010 Apr;41(4):470-7. doi: 10.1002/mus.21520.